Preview

Complex Issues of Cardiovascular Diseases

Advanced search

Heart rate variability reduction as a non-ivasive predictor of ventricular tachyarrythmias in patients with coronary artery disease

https://doi.org/10.17802/2306-1278-2019-8-4-16-25

Abstract

Highlights. The implantation of cardioverter-defibrillator is the most effective method for preventing sudden cardiac death. However, almost 25% patients have normally functioning CD at the 5-years follow-up. This has necessitated the search for new non-invasive diagnostic methods for detecting patients at high risk of ventricular tachyarrhythmias.

Aim. To evaluate whether the estimated heart rate variability may be used as a predictor for ventricular arrhythmias (VTA) in patients with coronary artery disease.

Methods. 51 patients (mean age of 65.4±8.4 year; 41 male patients (80,3%)) with coronary artery disease (CAD) and indications for cardioverter-defibrillator (ICD) implantation were included to the study. The 6-minute walk distance, echocardiography, heart rate variability (HRV) were assessed and compared between the groups. The statistical analysis was performed using the Statistica 10.0, StatSoft (USA) and MedCalc statistical software (USA).

Results. 43 (84.3%) patients with VTA within the 18-months follow-up were assigned to Group 1, and 8 (15.7%) patients without VTA during the 18-month follow-up were assigned to Group 2. The univariate ROC-analysis showed that a reduction in the average NN interval less than 1130 ms (p = 0.0282), root mean square of successive differences less than 18 ms (p = 0.0037) and high frequency spectral component less than 770 ms (p = 0.0001) contributed to the onset of of VTA. Multivariate ROC-analysis demonstrated that the end-diastolic index (p = 0.0185) and standard deviation of NN interval (p = 0.0370) were independent predictors of VTA. An increase of the VTA predictive index (calculated according to the presented predictive model) by >0.5613 suggested the onset of VTA (AUC = 0.927; p = 0.0001).

Conclusion. Reduced HRV may be a non-invasive VTA predictor in patients with CAD. The combined use of echocardiography and HRV analysis allows identifying a group of patients with high risk of sudden cardiac death.

About the Authors

T. A. Atabekov
Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences
Russian Federation

Atabekov TarielA. - PhD student, surgeon at the Department of Surgical Treatment of Complicated Cardiac Arrhythmias and Pacing.

634012, Tomsk, 111a, Kievskaya St.


Competing Interests: not


R. E. Batalov
Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences
Russian Federation

Batalov Roman E. - PhD, leading researcher at the Department of Surgical Treatment of Complicated Cardiac Arrhythmias and Pacing.

634012, Tomsk, 111a, Kievskaya St.


Competing Interests: not


S. N. Krivolapov
Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences
Russian Federation

Krivolapov Sergey N. -  interventional electrophysiologist at the Department of Surgical Treatment of Complicated Cardiac Arrhythmias and Pacing.

634012, Tomsk, 111a, Kievskaya St.


Competing Interests: not


M. S. Khlynin
Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences
Russian Federation

Khlynin Michail S. - PhD, researcher at the Department of Surgical Treatment of Complicated Cardiac Arrhythmias and Pacing.

634012, Tomsk, 111a, Kievskaya St.


Competing Interests: not


S. V. Popov
Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences
Russian Federation

Popov Sergey V. - PhD, Professor, Academician of the Russian Academy of Sciences, Director, Head of the Department of Surgical Treatment of Complicated Cardiac Arrhythmias and Pacing.

634012, Tomsk, 111a, Kievskaya St.


Competing Interests: not


References

1. Lopera G, Curtis AB. Risk stratification for sudden cardiac Rev. 2009;5(1):56-64. doi: 10.2174/157340309787048130. death: current approaches and predictive value. Curr Cardiol 2. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22(16):1374-450. doi: 10.1053/euhj.2001.2824.

2. Israel CW. Mechanisms of sudden cardiac death. Indian Heart J. 2014;66 Suppl 1:S10-7. doi: 10.1016/j.ihj.2014.01.005.

3. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Bloma N, Borggrefe M, Camm J, Perry ME, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck K-H, Hernandez A., Nikolaou N, Norekval TM, Spaulding C, Dirk J. Van Veldhuisen. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Russian Journal of Cardiology. 2016;7(135):5-86. (in Russian) doi: http://dx.doi.org/10.15829/1560-4071-2016-7-5-86.

4. Lee MS, Yang T, Dhoot J, Liao H. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowing. Am J Cardiol. 2010;105(8):1070-5. doi: 10.1016/j.amjcard.2009.12.007.

5. Merchant FM, Jones P, Wehrenberg S, Lloyd MS, Saxon LA. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assos. 2014;3(6). doi: 10.1161/JAHA.114.001289.

6. Bokeria LA, Bokeria OL, Volkovskaya IV Heart rate variability: measurement methods, interpretation, clinical use. Annals of Arrhythmology. 2009; 6 (4): 21-32. (in Russian)

7. Brateanu A. Heart rate variability after myocardial infarction: what we know and what we still need to find out. Curr Med Res Opin. 2015;31(10):1855-60. doi: 10.1185/03007995.2015.1086992.

8. Wilinski J, Sondej T, Kusiak A, Wilinski B, Kameczura T, Bacior B, Czarnecka D. Heart rate variability in the course of ST-segment elevation myocardial infarction treated with primary percutaneous transluminal coronary angioplasty in elderly and younger patients. Przeql Lek. 2014;71(2):61-5.

9. Song T, Qu XF, Zhang YT, Cao W, Han BH, Li Y, Piao JY, Yin LL, da Cheng H. Usefulness of the heart-rate variability complex for predicting cardiac mortality after acute myocardial infarction. BMC Cardiovasc Disord. 2014;14:59. doi: 10.1186/1471-2261-14-59.

10. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88(1):180-5. doi: 10.1161/01.cir.88.1.180.


Review

For citations:


Atabekov T.A., Batalov R.E., Krivolapov S.N., Khlynin M.S., Popov S.V. Heart rate variability reduction as a non-ivasive predictor of ventricular tachyarrythmias in patients with coronary artery disease. Complex Issues of Cardiovascular Diseases. 2019;8(4):16-25. (In Russ.) https://doi.org/10.17802/2306-1278-2019-8-4-16-25

Views: 2284


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)